FindTrial
Sign In

Is clobazam effective in preventing recurrences of febrile seizures

Intermittent clobazam therapy and febrile seizure recurrence- a double blind RCT

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/01/048994
Enrollment
130
Registered
2023-01-13
Start date
Unknown
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G998- Other specified disorders of nervous system in diseases classified elsewhere

Interventions

Intervention1: Clobazam group: Tab Clobazam 0.75mg/kg/day PO BD for 3 days from the onset of fever Control Intervention1: Placebo: Tab Placebo 0.75mg/kg/day PO BD for 3 days from the onset of fever

Sponsors

AIIMS JODHPUR
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: child between 6 months to 6 years of age will be enrolled

Exclusion criteria

Exclusion criteria: 1. Patients already on clobazam 2.Patients with known epilepsy syndromes 3.History of afebrile seizures 4. High suspicion of intracranial infections 5.Significant developmental delay

Design outcomes

Primary

MeasureTime frame
Number of recurrences of febrile seizures with intermittent clobazam versus placeboTimepoint: 6months follow up—

Secondary

MeasureTime frame
Adverse effects of clobazamTimepoint: 6 months follow up—

Countries

India

Contacts

Public ContactDr Lokesh Saini

All India institute of medical sciences Jodhpur

drlokeshsaini@gmail.com9968859725

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026